| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |